StockData
Bright Minds Biosciences Inc. logo

Bright Minds Biosciences Inc. (DRUG) stock

DRUGNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 40-F on Dec 23, 2025Score 5/30
$20.40−0.30 (-1.45%)

Close on Nov 20, 2026Market cap $155.77MP/E –Yield –

Bright Minds Biosciences operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

No operating income figures for Bright Minds Biosciences

Bright Minds Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Bright Minds Biosciences figures

See a number that looks wrong?